Orthofix (OFIX) Price & Analysis

Compare

82 Followers

OFIX Stock Chart & Stats

Day’s Range― - ―

52-Week Range$10.24 - $20.73

Previous CloseN/A

Volume45.16K

Average Volume (3M)461.61K

Market Cap

$580.96M

Enterprise Value$576.49M

Total Cash (Recent Filing)$65.61M

Total Debt (Recent Filing)$204.74M

Price to Earnings (P/E)―

Beta1.29

Next Earnings

Nov 06, 2025

EPS Estimate

-0.41

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.36

Shares Outstanding39,494,267

10 Day Avg. Volume406,538

30 Day Avg. Volume461,606

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.99

Enterprise Value/Revenue0.71

Enterprise Value/Gross Profit1.04

Enterprise Value/Ebitda156.53

Forecast

1Y Price Target

$19.50

Price Target Upside32.56% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering4

Bulls Say, Bears Say

Bulls Say

Growth StrategyThe company is executing on the key drivers for its near- and long-term plans, positioning it for future growth.

Product LaunchesThe company is working to accelerate growth through targeted new product launches, with recent FDA clearances supporting differentiation.

ValuationCurrent valuation of OFIX is attractive, trading significantly below comp group averages, supporting the BUY rating.

Bears Say

Market CompetitionOrthofix competes in spaces within medical technology that are sizable and should demonstrate solid organic growth over the next several years.

Orthofix News

Orthofix management to meet with Roth Capital

Meeting to be held in New York on September 23 hosted by Roth Capital. Published first on TheFly...

6d ago

OFIX

Orthofix: Strategic Initiatives and Strong Financial Performance Drive Buy Rating

Orthofix, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Caitlin Cronin from Canaccord...

1M ago

OFIX

Orthofix’s Strong Q2 Performance and Positive Outlook Justify Buy Rating

In a report released today, Michael Petusky from Barrington maintained a Buy rating on Orthofix, with a price...

2M ago

OFIX

Orthofix price target raised to $17 from $16 at Barrington

Barrington analyst Michael Petusky raised the firm’s price target on Orthofix (OFIX) to $17 from $16 and keeps...

2M ago

OFIX

Orthofix backs FY25 revenue view $808M-$816M, consensus $813.4M

Backs FY25 adjusted EBITDA view $82M-$86M. The company said, “Pro forma net sales expected to range between $808...

2M ago

OFIX

Orthofix reports Q2 EPS (36c) vs. (88c) last year

Reports Q2 revenue $203.12M, consensus $197.11M. “Orthofix’s (OFIX) second quarter results demonstrate clear progress on our three-year plan...

2M ago

OFIX

Orthofix Reports Q2 2025 Financial Results and Growth

Orthofix ( ($OFIX) ) just unveiled an announcement. Orthofix Medical Inc. reported its financial results for the second...

2M ago

OFIX

Is OFIX a Buy, Before Earnings?

Orthofix International (OFIX) is scheduled to report 2nd quarter earnings on 08/05/2025, before the market opens. Regarding Q2...

2M ago

OFIX

Orthofix initiated with an Outperform at Barrington

Barrington analyst Michael Petusky initiated coverage of Orthofix (OFIX) with an Outperform rating and $16 price target Orthofix...

3M ago

OFIX

Orthofix Shareholders Meeting and Board Elections

Orthofix ( ($OFIX) ) has shared an update. On June 18, 2025, Orthofix Medical Inc. held its annual...

3M ago

OFIX

Needham medtech & diagnostics analyst holds analyst/industry conference call

Med Tech & Diagnostics Analyst Saxon discusses spinal implants, enabling technologies, spinal cord stimulation, and the potential impact...

4M ago

JNJ

MDT

Orthofix Medical Reports Q1 2025 Financial Growth

Orthofix International ( ($OFIX) ) has released its Q1 earnings. Here is a breakdown of the information Orthofix...

5M ago

OFIX

Orthofix Earnings Call: Growth Amid Challenges

Orthofix International (($OFIX)) has held its Q1 earnings call. Read on for the main highlights of the call....

5M ago

OFIX

Orthofix cuts FY25 revenue view to $808M-$816M from $818M-$826M

Consensus $821.98M. Backs FY25 adjusted EBITDA view $82M-$86M. The company said, “Net sales now expected to range between...

5M ago

OFIX

OFIX FAQ

What was Orthofix International N.V.’s price range in the past 12 months?

Orthofix International N.V. lowest stock price was $10.24 and its highest was $20.73 in the past 12 months.

What is Orthofix International N.V.’s market cap?

Orthofix International N.V.’s market cap is $580.96M.

When is Orthofix International N.V.’s upcoming earnings report date?

Orthofix International N.V.’s upcoming earnings report date is Nov 06, 2025 which is in 46 days.

How were Orthofix International N.V.’s earnings last quarter?

Orthofix International N.V. released its earnings results on Jun 30, 2025. The company reported -$0.36 earnings per share for the quarter, beating the consensus estimate of -$0.49 by $0.13.

Is Orthofix International N.V. overvalued?

According to Wall Street analysts Orthofix International N.V.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Orthofix International N.V. pay dividends?

Orthofix International N.V. does not currently pay dividends.

What is Orthofix International N.V.’s EPS estimate?

Orthofix International N.V.’s EPS estimate is -0.41.

How many shares outstanding does Orthofix International N.V. have?

Orthofix International N.V. has 39,494,267 shares outstanding.

What happened to Orthofix International N.V.’s price movement after its last earnings report?

Orthofix International N.V. reported an EPS of -$0.36 in its last earnings report, beating expectations of -$0.49. Following the earnings report the stock price went up 0.541%.

Which hedge fund is a major shareholder of Orthofix International N.V.?

Currently, no hedge funds are holding shares in OFIX

Orthofix Stock Smart Score

Neutral

Fundamentals

Return on Equity

-24.63%

Trailing 12-Months

Asset Growth

-5.08%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Orthofix International N.V.

Orthofix Medical Inc. is a global medical device company focused on providing innovative solutions for spinal and orthopedic conditions. The company operates primarily in two segments: Orthopedic and Spine, offering a range of products including bone growth stimulators, surgical implants, and regenerative medicine solutions. Orthofix is dedicated to improving patient outcomes through advanced technologies and is committed to research and development in the medical device industry.

Orthofix (OFIX) Earnings & Revenues

Historic Earnings Reports

OFIX Company Deck

OFIX Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

Orthofix has demonstrated positive net sales growth and strong performance in U.S. Orthopedics and BGT divisions, alongside successful product launches and strategic initiatives. However, challenges such as pricing pressures in the Spine Fixation segment, international Orthopedics decline, and tariff exposures present ongoing concerns.View all OFIX earnings summaries

OFIX Stock 12 Month Forecast

Average Price Target

$19.50

▲(32.56% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"9":"$9","13":"$13","17":"$17","21":"$21","25":"$25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":24,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$24.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$19.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[9,13,17,21,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.77,11.787692307692307,12.805384615384614,13.823076923076922,14.84076923076923,15.858461538461537,16.876153846153848,17.893846153846155,18.911538461538463,19.92923076923077,20.946923076923078,21.964615384615385,22.982307692307693,{"y":24,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.77,11.44153846153846,12.113076923076923,12.784615384615384,13.456153846153846,14.127692307692307,14.799230769230768,15.47076923076923,16.142307692307693,16.813846153846153,17.485384615384614,18.15692307692308,18.82846153846154,{"y":19.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,10.77,11.095384615384615,11.420769230769231,11.746153846153845,12.071538461538461,12.396923076923077,12.722307692307693,13.047692307692309,13.373076923076923,13.698461538461538,14.023846153846154,14.349230769230768,14.674615384615386,{"y":15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.06,"date":1711929600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.02,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.77,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.96,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":19.31,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.46,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.33,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.38,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.01,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.55,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.84,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.18,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.77,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >